Want to see HK:2373 full AI Analyst Report?
Top Page
Beauty Farm Medical & Health Industry, Inc.
(2373)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$17.00
▼(-35.51% Downside)
Action:Reiterated
Date:05/01/26
The score is driven primarily by solid financial performance (strong growth and improving margins) but is held back by higher leverage and some cash flow metric uncertainty. Technicals are a meaningful drag due to a sustained downtrend and negative momentum, while valuation is reasonable with a moderate P/E and a modest dividend yield.
Positive Factors
Revenue & Margin Expansion
Sustained top-line growth coupled with a meaningful margin improvement indicates the company is scaling its care facility operations profitably. Over 2–6 months this supports durable cash generation, reinvestment capacity, and resilience of core earnings versus peers in the medical care facilities industry.
Negative Factors
Rising Leverage
The sharp increase in leverage materially raises financial risk and reduces strategic flexibility. Higher debt levels can increase interest burden, constrain investment choices, and amplify downside in a revenue shock, making balance-sheet capacity a meaningful medium-term vulnerability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & Margin Expansion
Sustained top-line growth coupled with a meaningful margin improvement indicates the company is scaling its care facility operations profitably. Over 2–6 months this supports durable cash generation, reinvestment capacity, and resilience of core earnings versus peers in the medical care facilities industry.
Read all positive factors
Beauty Farm Medical & Health Industry, Inc. (2373) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$4.02B
Dividend Yield1.97%
Average Volume (3M)539.77K
Price to Earnings (P/E)10.0
Beta (1Y)0.47
Revenue Growth16.70%
EPS Growth38.98%
CountryHK
Employees5,609
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.38
Shares Outstanding251,593,720
10 Day Avg. Volume911,428
30 Day Avg. Volume539,766
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)5.54
Price to Sales (P/S)1.89
P/FCF Ratio6.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.33Price Target Upside18.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)1.79
Revenue Forecast (FY)HK$3.99B
Beauty Farm Medical & Health Industry, Inc. Business Overview & Revenue Model
Company Description
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty trea...
How the Company Makes Money
null...
Beauty Farm Medical & Health Industry, Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
56
Neutral
Cash Flow
62
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.00B | 2.57B | 2.15B | 1.64B | 1.78B |
| Gross Profit | 1.47B | 1.19B | 977.10M | 717.84M | 833.79M |
| EBITDA | 603.50M | 427.49M | 644.82M | 452.43M | 554.51M |
| Net Income | 317.56M | 228.46M | 215.66M | 103.11M | 193.47M |
Balance Sheet | |||||
| Total Assets | 5.05B | 4.28B | 3.30B | 2.50B | 2.48B |
| Cash, Cash Equivalents and Short-Term Investments | 2.57B | 1.83B | 1.57B | 910.63M | 1.08B |
| Total Debt | 1.29B | 730.59M | 563.12M | 525.50M | 515.46M |
| Total Liabilities | 3.98B | 3.30B | 2.47B | 2.29B | 2.21B |
| Stockholders Equity | 1.02B | 944.64M | 801.90M | 188.75M | 257.36M |
Cash Flow | |||||
| Free Cash Flow | 932.01M | 682.44M | 466.27M | 241.21M | 536.76M |
| Operating Cash Flow | 999.09M | 796.63M | 625.51M | 382.00M | 669.93M |
| Investing Cash Flow | -396.42M | -340.85M | -711.18M | 53.63M | -385.35M |
| Financing Cash Flow | 51.79M | -223.36M | 133.74M | -432.82M | -271.06M |
Beauty Farm Medical & Health Industry, Inc. Technical Analysis
Negative
26.36
Price Trends
19.11
Negative
21.10
Negative
25.68
Negative
Market Momentum
-0.72
Positive
30.46
Neutral
16.86
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2373, the sentiment is Negative. The current price of 26.36 is above the 20-day moving average (MA) of 17.61, above the 50-day MA of 19.11, and above the 200-day MA of 25.68, indicating a bearish trend. The MACD of -0.72 indicates Positive momentum. The RSI at 30.46 is Neutral, neither overbought nor oversold. The STOCH value of 16.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2373.
Beauty Farm Medical & Health Industry, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$372.44M | 11.37 | 4.28% | 7.10% | -2.78% | -24.77% | |
62 Neutral | HK$4.02B | 10.04 | 33.37% | 1.97% | 16.70% | 38.98% | |
60 Neutral | HK$1.03B | 31.68 | 1.27% | ― | ― | ― | |
54 Neutral | HK$1.50B | 105.24 | 0.48% | 0.49% | -2.63% | ― | |
52 Neutral | HK$5.36B | 107.84 | 0.60% | ― | -9.81% | -72.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$59.61M | 29.88 | 1.67% | ― | -4.86% | ― |
* Healthcare Sector Average
HK:2373
Beauty Farm Medical & Health Industry, Inc.
16.00
-13.76
-46.24%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.11
-0.02
-15.08%
HK:3886
Town Health International Medical Group Ltd.
0.22
-0.01
-6.36%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
8.72
-6.54
-42.86%
HK:6639
Arrail Group Ltd.
1.83
-0.22
-10.78%
HK:0722
UMP Healthcare Holdings Limited
0.47
0.02
4.03%
Beauty Farm Medical & Health Industry, Inc. Corporate Events
Beauty Farm Wins Strong Shareholder Backing at 2026 AGM
Jun 26, 2026
Beauty Farm Medical Health Industry Inc. reported that shareholders overwhelmingly approved all resolutions at its annual general meeting held in Hong Kong on 26 June 2026. The meeting confirmed the company’s audited financial statements fo...
Beauty Farm Updates Timetable for 2025 Final Dividend of HKD 0.72 Per Share
May 28, 2026
Beauty Farm Medical and Health Industry Inc. has announced an updated schedule for its final cash dividend for the year ended December 31, 2025, declaring a payout of HKD 0.72 per share subject to shareholder approval on June 26, 2026. The company...
Beauty Farm Sets 2026 AGM to Approve Dividend, Board Changes and Capital Mandates
May 28, 2026
Beauty Farm Medical and Health Industry Inc. has called its annual general meeting for June 26, 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended December 31, 2025 and vote on key corporate matte...
Beauty Farm Proposes Governance Upgrade With New Memorandum and Articles
May 26, 2026
Beauty Farm Medical Health Industry Inc. has proposed amendments to its existing constitutional documents, aiming to update its memorandum and articles of association to align with the latest regulatory requirements in Hong Kong. The revisions ar...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.